Intraoperative Application of Cold Atmospheric Plasma to Prevent Postoperative Wound Complications in the Inguinal Region of High-risk Patients With Peripheral Arterial Occlusive Disease (PICPAD)
Prophylactic Application of Cold Atmospheric Plasma to Reduce Postoperative Wound Healing Disorders in the Inguinal Region in High-risk Patients With Peripheral Arterial Occlusive Disease- Intraoperative Application of Cold Atmospheric Plasma in the Inguinal Region
The goal of this clinical trial is to learn if postoperative wound complications in the inguinal region of high-risk patients with peripheral arterial occlusive disease can be prevented by the intraoperative application of cold atmospheric plasma.
The main questions it aims to answer are:
Does the intraoperative application of cold atmospheric plasma reduce the need for surgical revision of inguinal wounds due to wound healing complications within 3 months postoperatively? Does the intraoperative application of cold atmospheric plasma reduce wound healing complications not requiring revision within 3 months postoperatively?
Researchers will compare the application of cold atmospheric plasma to a placebo (a deactivated look-alike device).
Participants will:
Undergo surgical treatment with femoral artery access due to their peripheral arterial occlusive disease, in accordance with the respective vascular surgery department standard of care.
Receive a single application of cold atmospheric plasma or, respectively, placebo in the area of their inguinal access wound during surgery (after subcutaneous closure and prior to skin closure).
Be regularly assessed for wound healing during the first postoperative 14 days as part of routine clinical care and undergo a final evaluation at 3 months. They will also be surveyed regarding their quality of life.
연구 개요
상태
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Ursula EM Werra, MD
- 전화번호: 0049+22147830757
- 이메일: ursula.werra@uk-koeln.de
연구 장소
-
-
North Rhine-Westphalia
-
Cologne, North Rhine-Westphalia, 독일, 50937
- Department of Vascular and Endovascular Surgery
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
- Age > 18 years
- Written informed consent
- Surgical treatment of peripheral arterial occlusive disease (PAOD) with femoral (inguinal) access
- High-risk patient for wound healing complications:
WHD (wound healing disorder) score ≥ 4 points:
Diabetes mellitus (2) Immunosuppression/steroid therapy (2) End-stage renal disease (2) Reinterventions (2) Peripheral arterial occlusive disease (1) Nicotine abuse (1) Obesity (BMI > 30) (1) Age > 80 years (1) Duration of surgery > 4 h (1) Blood loss > 1.5 L (1) Local radiotherapy/chemotherapy (1)
Exclusion Criteria:
- Pregnancy or breastfeeding
- Femoral access for an indication other than PAOD
- Preoperative local infection or infectious skin disease
- Life expectancy < 3 months
- Active infection of the ipsilateral extremity requiring systemic antibiotic therapy at the time of surgery
- Systemic antibiotic therapy at the time of surgery
- Use of coated incisional drapes (e.g., iodine-impregnated)
- Intraoperative use of anti-infective topical agents (e.g., Gentacoll, doxycycline, etc.)
- Use of fibrin sealants/thrombogenic adhesive substances above the fascia Planned postoperative prophylactic negative pressure wound therapy (NPWT)
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 방지
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 더블
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
활성 비교기: Intervention: Intraoperative application of cold atmospheric plasma
During surgery (after subcutaneous closure and prior to skin closure), patients receive a single application of cold atmospheric plasma in the area of their inguinal access wound.
|
Single intraoperative treatment of the wound edges and the subcutaneous tissue adjacent to the wound edges with cold atmospheric plasma after subcutaneous closure and prior to skin closure
|
|
가짜 비교기: Control: Intraoperative sham application mimicking cold atmospheric plasma
During surgery (after subcutaneous closure and prior to skin closure), patients receive a sham application mimicking cold atmospheric plasma in the area of the inguinal access wound.
|
Single intraoperative treatment of the wound edges and the subcutaneous tissue adjacent to the wound edges with sham device after subcutaneous closure and prior to skin closure
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
기간 |
|---|---|
|
Time to revision surgery due to inguinal wound healing complications
기간: within 3 months postoperatively
|
within 3 months postoperatively
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Number of wound healing complications not requiring surgical revision
기간: within 3 months postoperatively
|
within 3 months postoperatively
|
|
|
Time to MACE (major adverse cardiac events) (myocardial infarction, cardiovascular death, stroke)
기간: within 3 months postoperatively
|
within 3 months postoperatively
|
|
|
Time to MALE (major adverse limb events) (amputation, graft occlusion, unplanned repeat revascularization)
기간: within 3 months postoperatively
|
within 3 months postoperatively
|
|
|
course of patients quality of life over the course of wound healing
기간: within 3 months postoperatively
|
Patients will be provided with the EQ-5D-5L (European Quality of Life 5 Dimensions 5 Level Version) questionnaire in order to assess quality of life at the baseline visit as well as follow-up visits 3 and 4 and after 3 months (end of study visit). The EQ-5D-5L will be evaluated by converting responses across its five domains-mobility, self-care, usual activities, pain/discomfort, and anxiety/depression-into a single health utility index using a country-specific value set (e.g., German tariff), with possible values typically ranging from below 0 (worse than death) to 1 (full health). Each domain is rated on a 5-level scale, where 1 = no problems, 2 = slight problems, 3 = moderate problems, 4 = severe problems, and 5 = extreme problems/unable to perform. In addition, the EQ Visual Analogue Scale (EQ VAS) score will be analyzed separately, ranging from 0 (worst imaginable health) to 100 (best imaginable health). |
within 3 months postoperatively
|
|
course of estimated Glomerular Filtration Rate (eGFR) over the course of wound healing
기간: within 3 months postoperatively
|
According to clinical routine, blood samples will be collected at follow-up visits if clinically indicated, and the results will be evaluated, in this case: eGFR ml/min/1.73m²
|
within 3 months postoperatively
|
|
course of white blood cell count over the course of wound healing
기간: within 3 months postoperatively
|
According to clinical routine, blood samples will be collected at follow-up visits if clinically indicated, and the results will be evaluated, in this case: white blood cell count 10*9/L
|
within 3 months postoperatively
|
|
course of C- reaktive protein over the course of wound healing
기간: within 3 months postoperatively
|
According to clinical routine, blood samples will be collected at follow-up visits if clinically indicated, and the results will be evaluated, in this case: C- reaktive protein (mg/L)
|
within 3 months postoperatively
|
|
course of procalcitonin over the course of wound healing
기간: within 3 months postoperatively
|
According to clinical routine, blood samples will be collected at follow-up visits if clinically indicated, and the results will be evaluated, in this case: procalcitonin (ng/ml)
|
within 3 months postoperatively
|
|
course of hemoglobin over the course of wound healing
기간: within 3 months postoperatively
|
According to clinical routine, blood samples will be collected at follow-up visits if clinically indicated, and the results will be evaluated, in this case: hemoglobin g/dl
|
within 3 months postoperatively
|
|
course of platelets over the course of wound healing
기간: within 3 months postoperatively
|
According to clinical routine, blood samples will be collected at follow-up visits if clinically indicated, and the results will be evaluated, in this case: platelets 10*9/L
|
within 3 months postoperatively
|
|
Course of haematocrit over the course of wound healing
기간: within 3 months postoperatively
|
According to clinical routine, blood samples will be collected at follow-up visits if clinically indicated, and the results will be evaluated, in this case: haematocrit (%)
|
within 3 months postoperatively
|
|
course of albumin over the course of wound healing
기간: within 3 months postoperatively
|
According to clinical routine, blood samples will be collected at follow-up visits if clinically indicated, and the results will be evaluated, in this case: albumin (g/L)
|
within 3 months postoperatively
|
|
course of sodium over the course of wound healing
기간: within 3 months postoperatively
|
According to clinical routine, blood samples will be collected at follow-up visits if clinically indicated, and the results will be evaluated, in this case: sodium mmol/L
|
within 3 months postoperatively
|
|
course of potassium over the course of wound healing
기간: within 3 months postoperatively
|
According to clinical routine, blood samples will be collected at follow-up visits if clinically indicated, and the results will be evaluated, in this case: potassium (mmol/L)
|
within 3 months postoperatively
|
|
course of International Normalized Ratio (INR) over the course of wound healing
기간: within 3 months postoperatively
|
According to clinical routine, blood samples will be collected at follow-up visits if clinically indicated, and the results will be evaluated, in this case: INR
|
within 3 months postoperatively
|
|
course of partial thromboplastin time over the course of wound healing
기간: within 3 months postoperatively
|
According to clinical routine, blood samples will be collected at follow-up visits if clinically indicated, and the results will be evaluated, in this case:partial thromboplastin time (s)
|
within 3 months postoperatively
|
|
course of total cholersterol over the course of wound healing
기간: within 3 months postoperatively
|
According to clinical routine, blood samples will be collected at follow-up visits if clinically indicated, and the results will be evaluated, in this case: total cholesterol (mg/dl)
|
within 3 months postoperatively
|
|
course of low- density- lipoprotein cholesterol (LDL cholesterol) over the course of wound healing
기간: within 3 months postoperatively
|
According to clinical routine, blood samples will be collected at follow-up visits if clinically indicated, and the results will be evaluated, in this case: LDL cholesterol
|
within 3 months postoperatively
|
공동 작업자 및 조사자
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- PICPAD-2026-01
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .